BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

567 related articles for article (PubMed ID: 2153277)

  • 1. Prognostic significance of morphological parameters and flow cytometric DNA analysis in carcinoma of the breast.
    Visscher DW; Zarbo RJ; Greenawald KA; Crissman JD
    Pathol Annu; 1990; 25 Pt 1():171-210. PubMed ID: 2153277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: review of a series of 271 patients with stage I and II breast cancer].
    Moureau-Zabotto L; Bouchet C; Cesari D; Uzan S; Lefranc JP; Antoine M; Genestie C; Deniaud-Alexandre E; Bernaudin JF; Touboul E; Fleury-Feith J
    Cancer Radiother; 2005 Dec; 9(8):575-86. PubMed ID: 16243560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: analysis of a series of 271 patients with stage I and II breast cancer.
    Moureau-Zabotto L; Bouchet C; Cesari D; Uzan S; Lefranc JP; Antoine M; Genestie C; Deniaud-Alexandre E; Bernaudin JF; Touboul E; Fleury-Feith J
    Breast Cancer Res Treat; 2005 May; 91(1):61-71. PubMed ID: 15868432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S-phase fraction determined on fine needle aspirates is an independent prognostic factor in breast cancer - a multivariate study of 770 patients.
    Gazic B; Pizem J; Bracko M; Cufer T; Borstnar S; Pohar-Marinsek Z; Us-Krasovec M
    Cytopathology; 2008 Oct; 19(5):294-302. PubMed ID: 18070112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiparametric deoxyribonucleic acid and cell cycle analysis of breast carcinomas by flow cytometry. Clinicopathologic correlations.
    Visscher DW; Zarbo RJ; Jacobsen G; Kambouris A; Talpos G; Sakr W; Crissman JD
    Lab Invest; 1990 Mar; 62(3):370-8. PubMed ID: 1690316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative long-term prognostic value of quantitative HER-2/neu protein expression, DNA ploidy, and morphometric and clinical features in paraffin-embedded invasive breast cancer.
    Baak JP; Chin D; van Diest PJ; Ortiz R; Matze-Cok P; Bacus SS
    Lab Invest; 1991 Feb; 64(2):215-23. PubMed ID: 1671789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of DNA ploidy and proliferation in 309 colorectal carcinomas as determined by two-color multiparametric DNA flow cytometry.
    Zarbo RJ; Nakhleh RE; Brown RD; Kubus JJ; Ma CK; Mackowiak P
    Cancer; 1997 Jun; 79(11):2073-86. PubMed ID: 9179053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer cell kinetics: immunocytochemical determination of growth fractions by monoclonal antibody Ki-67 and correlation with flow cytometric S-phase and with some features of tumor aggressiveness.
    Gasparini G; Pozza F; Meli S; Reitano M; Santini G; Bevilacqua P
    Anticancer Res; 1991; 11(6):2015-21. PubMed ID: 1776834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of DNA image cytometry in Libyan breast cancer.
    Ermiah E; Abdalla F; Buhmeida A; Alshrad M; Salem N; Pyrhönen S; Collan Y
    Oncology; 2012; 83(3):165-76. PubMed ID: 22906963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutant p53 expression and DNA analysis in human breast cancer comparison with conventional clinicopathological parameters.
    Rosanelli GP; Steindorfer P; Wirnsberger GH; Klimpfinger M; Ratschek M; Puerstner P; Auner H; Berhold A
    Anticancer Res; 1995; 15(2):581-6. PubMed ID: 7763041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA analysis and S-phase fraction determination by flow cytometric analysis of infiltrating lobular carcinoma of the breast.
    Frost AR; Karcher DS; Terahata S; Siegel RS; Silverberg SG
    Mod Pathol; 1996 Sep; 9(9):930-7. PubMed ID: 8878026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive value of flow cytometry for metastatic potential in breast cancer.
    Schmidt H; Wei JP; Yeh KA
    Am Surg; 1999 May; 65(5):434-8. PubMed ID: 10231212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival of patients with metastatic breast carcinoma: importance of prognostic markers of the primary tumor.
    Chang J; Clark GM; Allred DC; Mohsin S; Chamness G; Elledge RM
    Cancer; 2003 Feb; 97(3):545-53. PubMed ID: 12548595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA analysis in advanced breast cancer.
    Leivonen M; Krogerus L; Nordling S
    Cancer Detect Prev; 1994; 18(2):87-96. PubMed ID: 8025900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reproducibility in DNA flow cytometric analysis of breast cancer: comparison of 12 laboratories' results for 67 sample homogenates.
    Baldetorp B; Bendahl PO; Fernö M; Alanen K; Delle U; Falkmer U; Hansson-Aggesjö B; Höckenström T; Lindgren A; Mossberg L
    Cytometry; 1995 Jun; 22(2):115-27. PubMed ID: 7587742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of DNA ploidy and S-phase fraction in stage I endometrial carcinoma.
    Pfisterer J; Kommoss F; Sauerbrei W; Rendl I; Kiechle M; Kleine W; Pfleiderer A
    Gynecol Oncol; 1995 Aug; 58(2):149-56. PubMed ID: 7622098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
    Ottesen GL
    APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors in breast cancer.
    Merkel DE; Osborne CK
    Hematol Oncol Clin North Am; 1989 Dec; 3(4):641-52. PubMed ID: 2558104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA flow cytometric analysis of clinical stage I endometrial carcinomas with lymph node metastases.
    Coleman RL; Schink JC; Miller DS; Bauer KD; August CZ; Rademaker AW; Lurain JR
    Gynecol Oncol; 1993 Jul; 50(1):20-4. PubMed ID: 8349159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. S-phase fraction and DNA ploidy in 633 T1T2 breast cancers: a standardized flow cytometric study.
    Chassevent A; Jourdan ML; Romain S; Descotes F; Colonna M; Martin PM; Bolla M; Spyratos F
    Clin Cancer Res; 2001 Apr; 7(4):909-17. PubMed ID: 11309341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.